12th International Paediatric Haematology & Oncology Update Meeting

Thursday 29th April 2010
08.00 – 09.50 Registration and Coffee
09.55 Introduction to the Meeting
Tim Eden, Paediatric and Adolescent Oncology Unit, University of Manchester, England
SESSION 1 CHAIRPERSONS: ANGELA THOMAS/TASNEEM KHALID
10.00 LECTURE 1
State of the Art for standard risk ALL – what are the essential issues?
Nick Goulden, Great Ormond Street Hospital, London, England
10.30 LECTURE 2
What can we do for high risk ALL? (including TYA & Relapse)
Vaskar Saha, Paediatric and Adolescent Oncology Unit, University of Manchester, England
11.00 LECTURE 3
What’s new/exciting in NHL State of the Art
Alfred Reiter
, Children’s University Hospital, Giessen, Germany
11.30 LECTURE 4
AML: does Transplantation have anything to offer?
Brenda Gibson, Royal Hospital for Sick Children, Glasgow, Scotland
12.00 – 12.15 Discussion
12.15 – 13.30 Lunch/Exhibition/Poster Viewing
SESSION 2 CHAIRPERSONS: CATHERINE WYNNE/LOUISE SOANES
13.30 LECTURE 5
Nephroblastoma – State of the Art – in Therapy and Science
Norbert Graf, SIOP Renal Tumours Study Group, Homburg, Germany
14.00 LECTURE 6
Germ Cell Tumours – a Clinical and Biological Update
Matthew Murray, MRC Clinical Research Training, Cambridge, England
14.30 – 14.45 Discussion
14.45 2 Clinical Conundrums/Case Presentations
15.15 – 15.40 Tea/Exhibition/Poster Viewing
SESSION 3 CHAIRPERSONS: TIM EDEN/KATE PYE
15.40 LECTURE 7
Essential Haematology for Oncologists: Blood Products, Risks and Special Circumstances
Helen New, Imperial College, London, England
16.10 LECTURE 8
Essential Haematology for Oncologists: Bleeding and Clotting
John Hanley, Newcastle Upon Tyne Hospital, England
16.40 LECTURE 9
Optimising Oral Care
Jan Clarkson
, University of Dundee, Scotland
17.00 – 17.15 Discussion
SESSION 4 CHAIRPERSONS: HAMISH WALLACE/ANGELA THOMAS
17.15 – 18.15

Survivorship – How should we follow up our patients?

  • What we don’t know
  • What can be done close to home – shared care
  • Research Essential
  • Nurse perspective

Featuring:
Dr Adam Glaser, Consultant Paediatric Oncologist, Leeds Teaching Hospitals NHS Trust and Clinical Director, National Cancer Survivor Initiative, Department of Health
Ms Susan Mehta, Clinical Nurse Specialist Long-Term Follow Up, Great Ormond Street Hospital
Ms Louise Barnes, Trainee Radiographer and Sarcoma Survivor, Essex

Followed by open audience debate
ANNOUNCEMENT OF THE 3 BEST POSTERS AT THE CONFERENCE

19.30 Gala Dinner
Friday 30th April 2010
08.00 – 09.00 Registration
08.15 SATELLITE SYMPOSIUM
RECENT ADVANCES IN REDUCED TOXICITY CONDITIONING
Pierre FabreSymposium supported by Pierre Fabre
Chair: Tasneem Khalid, Manchester
Speakers: Japp Boulens, University Medical Centre, Utrecht, The Netherlands
Paul Veys, Great Ormond Street Hospital, London, England
SESSION 5 CHAIRPERSONS: JAN KOHLER/TASNEEM KHALID
09.00 2 Clinical Conundrums/Case Presentations
09.30 LECTURE 10
Patterns of Tumour Incidence in Childhood
& TYA - what clues for causation?

Jill Birch, Paediatric and Familial Cancer Research Group, University of Manchester, England
10.00 LECTURE 11
Osteosarcoma - what is new in local and systemic Therapy?
Stefan Bielack, Hospital of Stuttgart, Germany
10.30 – 10.45 Discussion
10.45 – 11.15 Coffee/Exhibition/Poster Viewing
SESSION 6 CHAIRPERSONS: TIM EDEN/KATE PYE
11.15 LECTURE 12
Brain Tumours – the Pathway to Diagnosis
David Walker, University of Nottingham, England
Sophie Wilne, Birmingham Children’s Hospital, England
11.45 LECTURE 13
What the Patients tell us about how we listen
Faith Gibson, UCL Institute of Child Health and Great Ormond Street Hospital for Children, England
12.15 – 12.30 Discussion
12.30 – 13.30 Lunch/Exhibition/Poster Viewing
SESSION 7 CHAIRPERSONS: ANGELA THOMAS/CATHERINE WYNNE
13.30 Oral Presentations of the 3 Best Posters
14.15 LECTURE 14
Challenges for the Identification of new active Agents in Paediatric Oncology
Riccardo Riccardi, Catholic University of Rome, Italy
14.45 LECTURE 15
How can Pharmacokinetic Studies help us to optimise our Therapy? Does it matter?
Gareth Veal, Northern Institute for Cancer Research, Newcastle upon Tyne, England
15.15 – 15.30 Discussion
15.30 – 16.00 Tea/Exhibition/Poster Viewing
SESSION 8 CHAIRPERSONS: HAMISH WALLACE/LOUISE SOANES
16.00 LECTURE 16
GCP Matters: Getting the Trial right
Jan Kohler, Southampton Universities NHS Trust, England
GCP Matters: Getting the Medicine right
Jane Buckham, Paediatric Oncology Pharmacists Group, Sheffield Children’s Hospital, England
16.45 LECTURE 17
Can we translate what we have achieved into a Global Improvement in Childhood Cancer Survival?
Scott Howard, St Jude Children’s Research Hospital, Memphis, USA
17.15 Discussion
17.30 Close of Meeting

SOCIAL PROGRAMME – The Gala Dinner

Thursday 29th April 2010    Â£52.00 per person


For 2010, we will enjoy the luxurious and stylish surroundings of the Balmoral Hotel for our Gala Dinner.

SocialThe Balmoral Hotel is one of Edinburgh’s most famous landmarks, standing majestically at the end of Princes Street. Easy to find and offering superb views of Edinburgh Castle, the Hotel prides itself on offering top-quality banqueting suites and service.

The IPHOUM Gala Dinner is always popular and all colleagues are encouraged to attend to enjoy this opportunity for a relaxed evening together.

The ticket price includes reception drinks, a 3 course dinner, wine and music. Please book your ticket at the time of registering to ensure your place.

Dress code: Lounge suits


Web site by Cadet Technologies Ltd